European Patent (TR Translation)

Nmda Antagonisti Ön İlaçları.

Invention Abstract

Depresyon (özellikle majör depresif bozukluk) veya ağrı tedavisinde faydalı NMDA antagonisti olan (S)-1-fenil-2-(piridin-2- il)etanaminin ön ilaçları; bunları içeren bileşimler ve yapım yöntemleridir.

IPC Classes

C07D 401/14C07D 213/40A61K 31/4439C07D 401/12A61K 31/4402A61P 25/24

Parties

Inventor

Gunnar Nordvall C/O Astrazeneca Intellectual Property Astrazeneca R & D Alderley Alderley Park Macclesfield Cheshire Sk10 4tg İngiltere Katharına Hogdın C/O Astrazeneca Intellectual Property Astrazeneca R & D Alderley Alderley Park Macclesfield Cheshire Sk10 4tg İngiltere Per Jonas Malmborg C/O Astrazeneca Intellectual Property Astrazeneca R & D Alderley Alderley Park Macclesfield Cheshire Sk10 4tg İngiltere Mıchael Balestra C/O Astrazeneca Intellectual Property Astrazeneca R & D Boston 35 Gatehouse Drive Waltham Massachusetts 02451 A.B.D. Dırk Weıgelt C/O Astrazeneca Intellectual Property Astrazeneca R & D Alderley Alderley Park Macclesfield Cheshire Sk10 4tg İngiltere Peter Bernsteın C/O Astrazeneca Intellectual Property Astrazeneca R & D Boston 35 Gatehouse Drive Waltham Massachusetts 02451 A.B.D. Mıchael Quırk C/O Astrazeneca Intellectual Property Astrazeneca R & D Boston 35 Gatehouse Drive Waltham Massachusetts 02451 A.B.D. Annıka Kers C/O Astrazeneca Intellectual Property Astrazeneca R & D Alderley Alderley Park Macclesfield Cheshire Sk10 4tg İngiltere

Rights Holder

Astrazeneca Ab 151 85 Södertälje İsveç

Attorney

Tolga Çaylak (Dış Patent Marka Tescil Ve Danışmanlık Hiz. Ltd. Şti.) İçerenköy Değirmenyolu Cad. No:12/7 K:5 Ataşehir/İstanbul

This record is compiled from official TPMK patent bulletins and is provided for information. The abstract text is as published, in Turkish. The current legal status (opposition, assignment, invalidation) requires a full register review. Ask our experts for a comprehensive patent search.